Papers

2

Total Citations

13

H-Index

2

About

Dr. Jinrong Cheng is a surgical oncologist and translational researcher whose work bridges urologic oncology and tissue-based biomarker research. Her primary research areas include seminal vesicle tumors, prostate cancer pathology, and the optimization of surgical tissue procurement for molecular studies. Dr. Cheng’s most notable contribution is her comprehensive systematic review on mixed epithelial stromal tumors of the seminal vesicle, a rare and diagnostically challenging neoplasm. Published in 2022, this work has already garnered 9 citations, establishing a critical clinical reference for diagnosis and treatment. In a foundational 2015 study, Dr. Cheng investigated how intra-operative devascularization time during robot-assisted laparoscopic radical prostatectomy affects tissue quality. Her research demonstrated that minimizing the interval between devascularization and tissue procurement is essential for preserving cell number and RNA integrity, directly impacting the reliability of downstream genomic analyses. This work, with 4 citations, provides practical guidance for biobanking protocols in prostate cancer research. Dr. Cheng’s contributions are vital for advancing both rare tumor management and the methodological rigor of surgical tissue studies.

Research Focus

Key Achievements

2
H-Index
2
Papers
13
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Diagnosis and Treatment of a Mixed Epithelial Stromal Tumor of the Seminal Vesicle: A Systematic Review
9 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Montefiore Medical Center, Roswell Park Comprehensive Cancer Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago